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Abstract
Pleurocidin, a 25-residue a helical cationic peptide, isolated from skin mucous secretions of the winter flounder, displays a strong anti-
microbial activity and appears to play a role in innate host defence. This peptide would be responsible for pore formation in the membrane of
bacteria leading to lysis and therefore death. In this study, we investigated the behaviour of pleurocidin in different planar lipid bilayers to
determine its mechanism of membrane permeabilisation. Macroscopic conductance experiments showed that pleurocidin did not display a
pore-forming activity in neutral phosphatidylcholine/phosphatidylethanolamine (PC/PE) lipid bilayers. However, in 7:3:1 PC/PE/
phosphatidylserine (PS) lipid bilayers, pleurocidin showed reproducible I/V curves at different peptide concentrations. This activity is
confirmed by single-channel experiments since well-defined ion channels were obtained if the lipid mixture was containing an anionic lipid
(PS). The ion channel characteristics such as—no voltage dependence, only one unitary conductance, linear relation ship current–voltage—,
are not in favour of the membrane permeabilisation according to the barrel model but rather by the toroidal pore formation.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
During the past two decades, many antibacterial peptides
have been isolated and characterised from a broad variety of
animals and plants [1,2]. For more information, see the
databank of antimicrobial peptides and proteins: http://
www.bbcm.univ.trieste.it/~tossi/search.htm. Many of these
peptides are involved in the innate immune response to
bacterial aggressions and insure the first line of defence.
Broad anti-microbial spectra and weak resistance develop-
ments by bacteria make these compounds potential alter-
natives for the classic anti-biotherapy which is increasingly
confronted with the emergent problem of drug-resistant
pathogenic bacteria.
In invertebrates, since the first cecropin from Hyalophora
[3], many other anti-microbial peptides have been isolated
from different insect families [4–6]. In vertebrates, bomb-
inin was the first isolated peptide from skin secretions of
frog [7] followed by several other peptides such as mag-
ainins [8], brevinins [9] or dermaseptins [10]. In higher
vertebrates, including humans, defensins [11], cathelicidin
[12], protegrins [13] were also isolated and more recently
calcitermin [14] and hepcidin [15]. Although their primary
sequences are very different and their secondary structure
can be constituted of a-helices or h sheets or both, these
peptides possess often several positive charges and an
amphipathic character. These particularities seem to play
an essential role in different action mechanisms described in
the literature about the membrane permeabilisation involved
in the cell death. Briefly, three mechanisms are proposed in
the literature. In the first case, the membrane is permeabi-
lised by the formation of transmembrane pores composed of
a bundle of amphipathic helices according to the ‘‘barrel-
stave model’’ as observed in alamethicin [16,17]. In the
second case, lipids are inserted between helices to form a
mixed pore according to the ‘‘toroidal model’’ as described
for magainin [18,19]. In the last model, called ‘‘carpet-like
mechanism’’ peptides act as detergent and disrupt the
membrane via, eventually, the formation of transitory pores
[20]. Nevertheless, whatever the mechanism involved, the
first step is the peptide adsorption at the membrane surface.
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The interaction between peptide and bilayer is submitted to
important parameters such as charge, structure and amphi-
pathicity of peptides but also to the chemical composition of
lipids. Thus, the high proportion of negative charges in
gram-negative outer membrane would favour the electro-
static interaction with cationic peptides contrarily to eryth-
rocytes lipids which are mainly neutral or zwitterionic.
Recently, pleurocidin, a new peptide isolated from skin
mucosa of the winter flounder (Pseudopleuronectes ameri-
canus), was isolated and characterised [21]. This 25-amino-
acid-residue peptide presents a strong antibacterial activity
against gram-negative and gram-positive bacteria. Pleuro-
cidin shows primary sequence homology with dermaseptins
[22,23] and ceratatoxins [24,25] and like those possesses an
amphipathic a helical structure. More recently, CD meas-
urements and experiments of dye-leakage activity showed
that pleurocidin, like magainin, was able to form pores in
the lipid membrane [26]. However, there has been no direct
investigation to determine (i) the ability of pleurocidin to
form ion channels in lipid membranes and (ii) the action
mechanism used to permeabilise the bacterial membrane
leading to the death of bacteria. In this paper, we study the
behaviour of pleurocidin in neutral planar lipid bilayers as
well as in bilayers containing an acidic phospholipid, by
measuring its pore-forming activity and by determining its
single-channel characteristics. The results obtained allow us
to propose a mechanism of action involving the ‘‘toroidal
pore model’’ [19].
2. Materials and methods
Pleurocidin, a native peptide from skin secretions of
winter flounder, is a generous gift of G. Diamond (New
Jersey, USA). The sequence of this 25-residue peptide is
GWGSFFKKAAHVGKHVGKAALTHYL.
Phosphatidylcholine (PC) and phosphatidylethanolamine
(PE) grade 1 from egg yolk and phosphatidylserine (PS)
grade 1 from bovine spinal cord were purchased from Lipid
Products (Surrey, UK).
In macroscopic conductance experiments, virtually sol-
vent-free planar lipid bilayers were formed by the Montal
and Mueller technique [27]. The membrane was formed
over a 100- to 150-Am hole in a Teflon film (10 Am thick),
pre-treated with a mixture of 1:40 (v/v) hexadecane/hexane,
separating two half glass cells. Lipid monolayers were
spread on top of electrolyte solution (1 M KCl, 10 mM
Tris, pH 7.4) in both compartments. Bilayer formation was
achieved by lowering and raising the electrolyte level in one
or both sides and monitoring by capacity responses. The
lipid solution at 5 mg/ml was either a mixture of PC/PE 7:3
(w/w) or PC/PE/PS 7:3:1 (w/w). Voltage was applied
through an Ag/AgCl electrode in the cis side. Pleurocidin
wad added from a stock solution in MeOH (10  5 M). The
doped membranes were subjected to slow voltage ramps
(6.6 mV/s) and transmembrane currents were fed to a
Keitley amplifier (model 427). Current–voltage curves were
recorded on an X–Y plotter.
In single-channel recordings, lipid bilayers were formed
at the tip of fire-polished patch clamp pipettes pulled in two
steps by a Narishige pipette-puller (Tokyo, Japan) from
GB150 glass capillaries (Bio-Logic, Claix, France). Planar
lipid bilayers were formed according to the tip-dip technique
[28] with the same mixtures of lipids used in macroscopic
experiments but at 1 mg/ml.
Currents were amplified and potentials were applied
simultaneously by a patch-clamp amplifier (RK 300, Bio-
Logic). Single-channel currents were monitored on an
oscilloscope (R5103N, Tektronix, Beaverton, OR, USA)
and stored on a DAT recorder (DTR 1202, Bio-Logic) for
off-line analysis. For further analysis, Satori (V3.1, Intracel
Software, Royston, UK) and Sigma Plot (SPSS, Chicago,
IL, USA) were used. All experiments were performed at
Fig. 1. Macroscopic current–voltage curves (I/V) for pleurocidin at
different concentrations: (1) 5 10 8 M, (2) 10 7 M, (3) 6 10 7 M,
(4) 4 10 6 M. Lipids used were a 7:3:1 mixture of PC/PE/PS and the
electrolyte solution was 1 M KCl, 10 mM Tris, pH 7.4. The characteristic
voltages Vc were determined from crossings of traces with a reference
conductance which is represented by a dashed line. The macroscopic
current measurements were performed at room temperature and the I/V
curves were recorded at a potential sweep rate of 6.66 mV/s.
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room temperature. Data are presented as meanF S.E. for n
experiments. Data were filtered at 1 kHz before digitising at
4 kHz for analysis and traces were filtered at 300 Hz for
figures.
3. Results
3.1. Macroscopic current measurements
Pleurocidin was incorporated into PC/PE (7:3) planar
lipid bilayers formed according to the Montal–Mueller
technique [27]. Typically, after 30 min, the bilayer was
submitted to repetitive triangular voltage ramps. Despite
numerous experiments, no reproducible current voltage (I/V)
curves could be recorded and superimposed, ensuring that
partitioning equilibrium between membrane and peptide
was reached. It was necessary to impose high voltages to
incorporate peptide in bilayers and when incorporation
occurred, the bilayers broke. In a previous paper [26], the
authors showed by fluorescent measurements that the inter-
action between lipid and peptide is strongly increased if the
membrane contains a proportion of negative charges. For
that reason, new experiments were performed into PC/PE/
PS (7:3:1) lipid bilayers. In this case, I/V curves were
obtained at different concentrations of pleurocidin in 1 M
KCl electrolyte (Fig. 1). An exponential development of
membrane current above a voltage threshold was observed
for each concentration. As previously demonstrated for
alamethicin [29], the evolution of the I/V curves with the
peptide concentration allows to determine different thresh-
old voltages Vc. The graph Vc versus Ln[C] (Fig. 2) gave a
Fig. 2. Concentration dependence of I/V curves for pleurocidin. Lipids used
were a 7:3:1 mixture of PC/PE/PS. Electrolyte solution was 1 M KCl
buffered with 10 mM Tris at pH 7.4. The slope (Va) reflects the voltage
threshold shift resulting from an e-fold change in bath concentration.
Fig. 3. Single-channel recordings for pleurocidin in different lipid bilayers
formed at the tip of patch-clamp pipettes. Current measurements were
performed at room temperature in 1 M KCl electrolyte buffered with 10
mM Tris at pH 7.4. Pleurocidin concentration was 2 10 8 M. The close
state was represented by a horizontal bar.
Fig. 4. Single-channel current fluctuations induced by pleurocidin in a 7:3:1
PC/PE/PS bilayer at 60 mV with the associated amplitude histogram. Same
conditions as that of Fig. 3.
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straight line with a slope, Va, which is the concentration
dependence factor. The Va value of about 27 mV was
indicative of a high dependence concentration. In the same
way, the voltage increment resulting in an e-fold change in
conductance on the exponential branch of I/V curve is
characteristic of the voltage dependence. The found value
of 32 mV seems to indicate a weak voltage dependence in
contrast to the 6-mV value found for alamethicin for
instance [29]. Thus, the Va/Ve ratio called Napp,—which
represents the apparent number of monomers constituting
the pore-forming peptide aggregate according to the ‘‘barrel-
stave model’’—is not significant.
3.2. Single-channel recordings
The trends revealed in the macroscopic analysis in PC/PE
were confirmed at the single-channel level. In fact, when
bilayers were formed at the tip of patch pipettes from this
lipid mixture, no discrete current fluctuations were observed
in a voltage range of  100 to + 100 mV (e.g. at 60 mV in
Fig. 3). If the voltage is increased to 120 mV, noisy current
fluctuations could be observed but in that case, membranes
became very fragile and broke rapidly (Fig. 3). However,
when a PC/PE/PS membrane was used, numerous well-
defined single channels were observed at 60 mV (Fig. 3).
For several current traces at 60 mV in a PC/PE/PS
mixture (Fig. 4), amplitude histograms were obtained and
allowed us to estimate at 100 pS the mean conductance
value in 1 M KCl (Fig. 4). Very rarely it was possible to see
a second level of same conductance. For five experiments at
60 mV, an opening channel probability of 0.59 was calcu-
lated and a mean lifetime value of channels could be
estimated at 14F 4 ms. These high values agree with a
good incorporation of peptides through the membrane and
their ability to form stable ion channels.
To confirm the weak voltage dependence observed in
macroscopic recordings, different experiments were per-
formed at several voltages. The current voltage relationship
for the open channel (Fig. 5) was linear and the average
slope conductance of unitary currents gave 100F 5 pS, a
close value of the one found for an alamethicin tetramer
(120 pS) [30].
4. Discussion
Pleurocidin, a 25-mer cationic peptide isolated from the
winter flounder, presents a broad antibacterial activity [21]
which could be due to its ability to permeabilise bacterial
membranes. The helical wheel diagram of pleurocidin
shows an amphipathic a helical conformation confirmed
by CD measurements in DOPC/DOPG (3:1) vesicles [26].
Moreover, by using spectrometry of tryptophan fluorescence
and dye-leakage experiments, the authors suggested that
pleurocidin, like magainin, was able to form pores in the
lipid membrane. However, no direct evidences showed that
pleurocidin is capable of forming ion channels in reconsti-
tution experiments. In addition, the different experiments
described about this peptide in the literature are not suffi-
cient to decide among the several proposed mechanisms
which is the one used by pleurocidin to permeabilise the
bacterial membranes. Consequently, the behaviour of pleu-
rocidin was investigated by conducting different reconstitu-
tion experiments in artificial planar lipid bilayers.
The I/V curves and single channel experiments showed a
weak incorporation of pleurocidin in neutral bilayers since
no ion channels were observed in a bilayer composed of a
7:3 mixture of PC/PE. In fact, if the voltage is strongly
increased, the incorporation would occur but the membrane
then becomes leaky and unstable. This behaviour is remi-
niscent of an amphipathic vector peptide whose incorpora-
tion was voltage dependent [31]. On the contrary, when the
used planar bilayer contains a proportion of anionic lipid
(PS), pleurocidin shows (i) reproducible I/V curves at differ-
ent concentrations and (ii) at different voltages, well-defined
single channels characterised by a high open channel
probability and long open state lifetimes. This behaviour
agrees with tryptophan fluorescence shift measurements
which demonstrated that pleurocidin interacts weakly with
a neutral phospholipid but strongly with an anionic phos-
pholipid [26]. Two peptides, dermaseptin from frog skin
[32] and ceratotoxin from medfly [33] which present 68%
and 50% of similarities with pleurocidin, respectively, also
presented a strong affinity for anionic lipids. Thus, the
presence of anionic lipid seems important to favour the
interaction between lipid and peptide, as already observed
with other anti-microbial cationic peptides [34]. This would
explain the strong interaction generally observed between
Fig. 5. Single current–voltage relations displayed by pleurocidin. Electro-
lyte was 1 M KCl buffered at pH 7.4 by 10 mM Tris. Room temperature.
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these cationic peptides and the anionic outer membrane of
gram-negative bacteria.
If the first step is common to the three mechanisms of
membrane permeabilisation mentioned previously [20,35],
the second step can occur (i) by formation of helical bundle
according to the barrel stave model, (ii) by formation of
toroidal pore including lipid molecules between the helices
[19], and (iii) by disruption of the membrane according to
the ‘‘carpet-like’’ mechanism. The I/V curves obtained with
pleurocidin allowed us to determine the characteristic Va
and Ve values [29]. The 27-mV value calculated for Va
indicates a high concentration dependence while the 32-mV
Ve value (compared to 6-mV of alamethicin [29]) shows
that pleurocidin does not induce voltage-dependent chan-
nels. This behaviour is confirmed by the applied voltage
values requested to induce ion channels since we were able
to observe pore-forming activity under a 60-mV voltage.
Moreover, the linear relationship I/V and the unique con-
ductance value of 100 pS observed from single-channel
experiments do not support a barrel stave model. Firstly, in
this model, the uptake and release of peptides in the
conducting aggregate modify the pore size and thus induce
different levels of conductance. Secondly, the graph I/V in
this case is not linear because the increments between the
different conductance values are not proportional to the
increase of the pore diameter. In a previous study, we
observed a similar behaviour with magainin [36]. We
showed that magainin presented only two main conduc-
tance levels occurring independently in separate trials. We
assumed that pre-aggregates lying on the membrane surface
at rest and drawn into the bilayer upon voltage application
in a behaviour contrasting with the classical multi-states
displayed by alamethicin. Another common point between
magainin and pleurocidin is the large polar sector devel-
oped in their helical wheel projection. In contrast, alame-
thicin, the archetype of the barrel stave model, presents a
narrow polar sector which forms the hydrophilic pore after
association of several molecules by strong hydrophobic
interactions. It seems that the amphipathic character of
helices is an important factor to explain the auto association
of peptides before embedment in the membrane according
to one or other mechanism. When this hydrophilic sector
increases, the ion channel characteristics of the barrel stave
model would disappear. This conclusion is supported by a
recent study [37] where the authors, from two synthetic
peptides possessing polar angles of 100 and 180j, showed
that this parameter was essential in determining peptide–
lipid interactions. Thus, like magainin, the toroidal model
seems more appropriate to explain the pore-forming proper-
ties of pleurocidin.
In this study, we concluded that antibacterial properties
of pleurocidin are likely due to the formation of ion
pathways in bacterial membrane. From our experiments,
we ruled out the ‘‘barrel-stave’’ model and deduced that
the toroidal model was the most appropriate one. Recent
studies emphasise that there is no contradiction between
the carpet and the toroidal models since the second could
occur complementary to the first one [38,39]. The differ-
ent characteristics of the ionophoric behaviour described
in this paper suggest that the action mechanism of
membrane permeabilisation by pleurocidin could occur
by the ‘‘carpet’’ mechanism via the formation of toroidal
pores.
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